Literature DB >> 20658973

Unravelling protein-protein interactions between complement factor H and C-reactive protein using a multidisciplinary strategy.

Stephen J Perkins1, Azubuike I Okemefuna, Ruodan Nan.   

Abstract

Experimental studies of protein-protein interactions are very much affected by whether the complexes are fully formed (strong, with nanomolar dissociation constants) or partially dissociated (weak, with micromolar dissociation constants). The functions of the complement proteins of innate immunity are governed by the weak interactions between the activated proteins and their regulators. Complement is effective in attacking pathogens, but not the human host, and imbalances in this process can lead to disease conditions. The inherent complexity in analysing complement interactions is augmented by the multivalency of its main regulator, CFH (complement factor H), for its physiological or pathophysiological ligands. The unravelling of such weak protein-protein or protein-ligand interactions requires a multidisciplinary approach. Synchrotron X-ray solution scattering and constrained modelling resulted in the determination of the solution structure of CFH and its self-associative properties, whereas AUC (analytical ultracentrifugation) identified the formation of much larger CFH multimers through the addition of metals such as zinc. The ligands of CFH, such as CRP (C-reactive protein), also undergo self-association. The combination of X-rays and AUC with SPR (surface plasmon resonance) proved to be essential to identify CRP self-association and revealed how CFH interacts with CRP. We show that CRP unexpectedly binds to CFH at two non-contiguous sites and explain its relevance to age-related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658973     DOI: 10.1042/BST0380894

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  7 in total

Review 1.  Structural and molecular changes in the aging choroid: implications for age-related macular degeneration.

Authors:  K R Chirco; E H Sohn; E M Stone; B A Tucker; R F Mullins
Journal:  Eye (Lond)       Date:  2016-10-07       Impact factor: 3.775

2.  Sequence divergence in the Treponema denticola FhbB protein and its impact on factor H binding.

Authors:  D P Miller; J V McDowell; D V Rhodes; A Allard; M Caimano; J K Bell; R T Marconi
Journal:  Mol Oral Microbiol       Date:  2013-04-22       Impact factor: 3.563

3.  The Treponema denticola FhbB Protein Is a Dominant Early Antigen That Elicits FhbB Variant-Specific Antibodies That Block Factor H Binding and Cleavage by Dentilisin.

Authors:  Daniel P Miller; Lee D Oliver; Brittney K Tegels; Lucas A Reed; Nathaniel S O'Bier; Kurni Kurniyati; Lindsay A Faust; Christine K Lawson; Anna M Allard; Melissa J Caimano; Richard T Marconi
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

4.  Zinc binding to the Tyr402 and His402 allotypes of complement factor H: possible implications for age-related macular degeneration.

Authors:  Ruodan Nan; Irene Farabella; Felix F Schumacher; Ami Miller; Jayesh Gor; Andrew C R Martin; David T Jones; Imre Lengyel; Stephen J Perkins
Journal:  J Mol Biol       Date:  2011-03-17       Impact factor: 5.469

5.  Complement factor H, vitronectin, and opticin are tyrosine-sulfated proteins of the retinal pigment epithelium.

Authors:  Yogita Kanan; Joseph C Siefert; Michael Kinter; Muayyad R Al-Ubaidi
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

6.  CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation.

Authors:  Demetrios G Vavvas; Kent W Small; Carl C Awh; Brent W Zanke; Robert J Tibshirani; Rafal Kustra
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

7.  Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces.

Authors:  Amy J Osborne; Ruodan Nan; Ami Miller; Jayesh S Bhatt; Jayesh Gor; Stephen J Perkins
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.